210 related articles for article (PubMed ID: 30074136)
1. Epidermal growth factor receptor-mediated regulation of matrix metalloproteinase-2 and matrix metalloproteinase-9 in MCF-7 breast cancer cells.
Majumder A; Ray S; Banerji A
Mol Cell Biochem; 2019 Feb; 452(1-2):111-121. PubMed ID: 30074136
[TBL] [Abstract][Full Text] [Related]
2. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
Farabegoli F; Papi A; Orlandi M
Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
[TBL] [Abstract][Full Text] [Related]
3. EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line.
Kim S; Choi JH; Lim HI; Lee SK; Kim WW; Cho S; Kim JS; Kim JH; Choe JH; Nam SJ; Lee JE; Yang JH
Cell Signal; 2009 Jun; 21(6):892-8. PubMed ID: 19385051
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells.
Kondapaka SB; Fridman R; Reddy KB
Int J Cancer; 1997 Mar; 70(6):722-6. PubMed ID: 9096655
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells.
Tang FY; Chiang EP; Sun YC
J Nutr Biochem; 2008 May; 19(5):287-94. PubMed ID: 17651959
[TBL] [Abstract][Full Text] [Related]
6. Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium.
Das S; Banerji A; Frei E; Chatterjee A
Life Sci; 2008 Feb; 82(9-10):467-76. PubMed ID: 18243246
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor regulates MT1-MMP and MMP-2 synthesis in SiHa cells via both PI3-K/AKT and MAPK/ERK pathways.
Zhang Z; Song T; Jin Y; Pan J; Zhang L; Wang L; Li P
Int J Gynecol Cancer; 2009 Aug; 19(6):998-1003. PubMed ID: 19820359
[TBL] [Abstract][Full Text] [Related]
8. Proximal events in signaling by plasma membrane estrogen receptors.
Razandi M; Pedram A; Park ST; Levin ER
J Biol Chem; 2003 Jan; 278(4):2701-12. PubMed ID: 12421825
[TBL] [Abstract][Full Text] [Related]
9. PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells.
Cowden Dahl KD; Zeineldin R; Hudson LG
Mol Cancer Res; 2007 May; 5(5):413-21. PubMed ID: 17475671
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
[TBL] [Abstract][Full Text] [Related]
11. Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands.
O-charoenrat P; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Clin Exp Metastasis; 1999; 17(7):631-9. PubMed ID: 10845563
[TBL] [Abstract][Full Text] [Related]
12. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
13. Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells.
Mitropoulou TN; Tzanakakis GN; Kletsas D; Kalofonos HP; Karamanos NK
Int J Cancer; 2003 Mar; 104(2):155-60. PubMed ID: 12569569
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association.
Ellerbroek SM; Halbleib JM; Benavidez M; Warmka JK; Wattenberg EV; Stack MS; Hudson LG
Cancer Res; 2001 Mar; 61(5):1855-61. PubMed ID: 11280738
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells.
Alper O ; Bergmann-Leitner ES; Bennett TA; Hacker NF; Stromberg K; Stetler-Stevenson WG
J Natl Cancer Inst; 2001 Sep; 93(18):1375-84. PubMed ID: 11562388
[TBL] [Abstract][Full Text] [Related]
16. Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes.
Portik-Dobos V; Harris AK; Song W; Hutchinson J; Johnson MH; Imig JD; Pollock DM; Ergul A
Am J Physiol Regul Integr Comp Physiol; 2006 Feb; 290(2):R435-41. PubMed ID: 16239374
[TBL] [Abstract][Full Text] [Related]
17. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways.
Park CM; Park MJ; Kwak HJ; Lee HC; Kim MS; Lee SH; Park IC; Rhee CH; Hong SI
Cancer Res; 2006 Sep; 66(17):8511-9. PubMed ID: 16951163
[TBL] [Abstract][Full Text] [Related]
18. 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases.
Xie Z; Yuan H; Yin Y; Zeng X; Bai R; Glazer RI
BMC Cancer; 2006 Mar; 6():77. PubMed ID: 16551362
[TBL] [Abstract][Full Text] [Related]
19. Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A.
Yeh MW; Rougier JP; Park JW; Duh QY; Wong M; Werb Z; Clark OH
Endocr Relat Cancer; 2006 Dec; 13(4):1173-83. PubMed ID: 17158762
[TBL] [Abstract][Full Text] [Related]
20. Induction of membrane-type-1 matrix metalloproteinase by epidermal growth factor-mediated signaling in gliomas.
Van Meter TE; Broaddus WC; Rooprai HK; Pilkington GJ; Fillmore HL
Neuro Oncol; 2004 Jul; 6(3):188-99. PubMed ID: 15279711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]